Aetna Inc (AET) is WINTON GROUP Ltd’s 8th Largest Position
WINTON GROUP Ltd raised its position in Aetna Inc (NYSE:AET) by 23.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 202,796 shares of the company’s stock after buying an additional 38,360 shares during the quarter. Aetna comprises about 1.0% of WINTON GROUP Ltd’s portfolio, making the stock its 8th largest position. WINTON GROUP Ltd’s holdings in Aetna were worth $37,213,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Cornerstone Advisors Inc. increased its holdings in Aetna by 263.6% in the 1st quarter. Cornerstone Advisors Inc. now owns 600 shares of the company’s stock valued at $101,000 after buying an additional 435 shares during the period. Bruderman Asset Management LLC bought a new position in Aetna in the 1st quarter valued at about $118,000. Kaizen Advisory LLC increased its holdings in Aetna by 143.9% in the 2nd quarter. Kaizen Advisory LLC now owns 766 shares of the company’s stock valued at $141,000 after buying an additional 452 shares during the period. CSat Investment Advisory L.P. bought a new position in Aetna in the 2nd quarter valued at about $162,000. Finally, Sun Life Financial INC increased its holdings in Aetna by 252.0% in the 2nd quarter. Sun Life Financial INC now owns 887 shares of the company’s stock valued at $163,000 after buying an additional 635 shares during the period. 83.45% of the stock is currently owned by hedge funds and other institutional investors.
AET opened at $204.89 on Tuesday. Aetna Inc has a 1-year low of $149.69 and a 1-year high of $205.58. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 0.74. The company has a market capitalization of $66.38 billion, a PE ratio of 20.78, a P/E/G ratio of 1.74 and a beta of 0.68.
Several equities analysts have commented on AET shares. Cantor Fitzgerald lowered shares of Aetna from an “overweight” rating to a “neutral” rating and set a $202.00 target price on the stock. in a report on Wednesday, August 22nd. Zacks Investment Research raised shares of Aetna from a “sell” rating to a “hold” rating in a report on Monday, August 6th. Finally, ValuEngine lowered shares of Aetna from a “buy” rating to a “hold” rating in a report on Friday, June 1st. Eight analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $200.38.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Featured Story: Fundamental Analysis
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.